Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 GX-188E placebo-controlled trial in HPV16/18-positive cervical intraepithelial neoplasia
2014-004721-40Phase 2Completed
- Sponsor
- Genexine
- Start
- Jan 2015
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cervical intraepithelial neoplasia (CIN) and human papillomavirus infection comparing GX-188E with Placebo (2 arms). Started Jan 2015; status: completed.
02
Drugs
tirvalimogene teraplasmid
03
Conditions
cervical intraepithelial neoplasia (CIN)human papillomavirus infection
Beyond the preview
Go deeper on 2014-004721-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004721-40.